Nucleic acids encoding plasminogen fragments
AssigneeChildren's Medical Center Corporation
InventorsM. JUDAH FOLKMAN, MICHAEL S. O'REILLY, YIHAI CAO
Life of this patent
Estimating the term…
Abstract
Fragments of an endothelial cell proliferation inhibitor and method of use therefor are provided. The endothelial proliferation inhibitor is a protein derived from plasminogen, or more specifically is an angiostatin fragment. The angiostatin fragments generally correspond to kringle structures occurring within the endothelial cell proliferation inhibitor. The endothelial cell inhibiting activity of these fragments provides a means for inhibiting angiogenesis of tumors and for treating angiogenic-mediated disease.
Claims63
A method of inhibiting endothelial cell proliferation comprising administering to an endothelial cell a proliferation inhibiting amount of an angiostatin fragment.
A method of treating a mammal with an angiogenic-mediated disease comprising administering to the mammal a treatment effective amount of an angiostatin fragment.
A therapeutic composition for inhibiting endothelial cell proliferation comprising a substantially isolated angiostatin fragment and a pharmaceutically acceptable excipient.
A composition comprising an isolated DNA sequence that codes for an angiostatin fragment having an endothelial cell proliferation inhibiting activity.
A method of expressing angiostatin fragment having an endothelial cell proliferation inhibiting activity comprising transfecting in a mammalian cell a vector, wherein the vector contains a DNA sequence encoding said angiostatin fragment, and wherein the vector is capable of expressing angiostatin fragment when present in the cell.
Dependencies are inferred from the claim text.